Michihiko Iijima

2.3k total citations
31 papers, 2.0k citations indexed

About

Michihiko Iijima is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Michihiko Iijima has authored 31 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 13 papers in Pharmacology and 9 papers in Biological Psychiatry. Recurrent topics in Michihiko Iijima's work include Neuroscience and Neuropharmacology Research (15 papers), Treatment of Major Depression (13 papers) and Tryptophan and brain disorders (9 papers). Michihiko Iijima is often cited by papers focused on Neuroscience and Neuropharmacology Research (15 papers), Treatment of Major Depression (13 papers) and Tryptophan and brain disorders (9 papers). Michihiko Iijima collaborates with scholars based in Japan, United States and Netherlands. Michihiko Iijima's co-authors include Shigeyuki Chaki, Hiroyuki Koike, Kenichi Fukumoto, Toshiharu Shimazaki, Shigenobu Shibata, Takeo Funakoshi, Kenji Hashimoto, Takashi Hashihayata, Hidetoh Toki and Junichi Yamaguchi and has published in prestigious journals such as Brain Research, Neuroscience and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Michihiko Iijima

31 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michihiko Iijima Japan	25	1.1k	944	926	385	352	31	2.0k
Elisa S. Na United States	16	1.1k 1.1×	996 1.1×	973 1.1×	400 1.0×	164 0.5×	26	2.6k
Cheryl L. Mayo United States	13	797 0.8×	889 0.9×	807 0.9×	358 0.9×	97 0.3×	18	1.9k
Francis Rodriguez Bambico Canada	26	1.7k 1.6×	1.7k 1.8×	636 0.7×	452 1.2×	356 1.0×	42	3.1k
Indira Mendez‐David France	25	1.2k 1.1×	599 0.6×	824 0.9×	768 2.0×	127 0.4×	43	2.7k
Piotr Gruca Poland	28	841 0.8×	343 0.4×	690 0.7×	657 1.7×	187 0.5×	86	1.9k
Laura Musazzi Italy	33	1.4k 1.4×	650 0.7×	1.1k 1.2×	898 2.3×	199 0.6×	77	3.1k
Agnieszka Nikiforuk Poland	31	1.3k 1.2×	598 0.6×	431 0.5×	288 0.7×	227 0.6×	91	2.9k
Beata Karolewicz United States	19	1.2k 1.1×	636 0.7×	850 0.9×	429 1.1×	69 0.2×	29	2.0k
Nasser Haddjeri France	33	2.3k 2.1×	991 1.0×	485 0.5×	385 1.0×	166 0.5×	92	3.4k
Giulia Treccani Denmark	17	691 0.7×	431 0.5×	766 0.8×	552 1.4×	68 0.2×	35	1.7k

Countries citing papers authored by Michihiko Iijima

Since Specialization

Citations

This map shows the geographic impact of Michihiko Iijima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michihiko Iijima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michihiko Iijima more than expected).

Fields of papers citing papers by Michihiko Iijima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michihiko Iijima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michihiko Iijima. The network helps show where Michihiko Iijima may publish in the future.

Co-authorship network of co-authors of Michihiko Iijima

This figure shows the co-authorship network connecting the top 25 collaborators of Michihiko Iijima. A scholar is included among the top collaborators of Michihiko Iijima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michihiko Iijima. Michihiko Iijima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dong, Chao, et al.. (2021). Antidepressant-like actions of the mGlu2/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram. Pharmacology Biochemistry and Behavior. 212. 173316–173316. 12 indexed citations

Kamiya, Makoto, Maurizio Fava, Charles B. Nemeroff, et al.. (2020). Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study. Journal of Psychiatric Research. 128. 43–51. 25 indexed citations

Kobayashi, Yuki, et al.. (2018). Depression-resistant Phenotype in Mice Overexpressing Regulator of G Protein Signaling 8 (RGS8). Neuroscience. 383. 160–169. 13 indexed citations

Fukumoto, Kenichi, Michihiko Iijima, Takeo Funakoshi, & Shigeyuki Chaki. (2018). 5-HT1A receptor stimulation in the medial prefrontal cortex mediates the antidepressant effects of mGlu2/3 receptor antagonist in mice. Neuropharmacology. 137. 96–103. 26 indexed citations

Fukumoto, Kenichi, Hidetoh Toki, Michihiko Iijima, et al.. (2017). Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine. Journal of Pharmacology and Experimental Therapeutics. 361(1). 9–16. 200 indexed citations

Chaki, Shigeyuki, et al.. (2015). Antidepressant/anxiolytic potential and adverse effect liabilities of melanin-concentrating hormone receptor 1 antagonists in animal models. Pharmacology Biochemistry and Behavior. 135. 154–168. 14 indexed citations

Fukumoto, Kenichi, Michihiko Iijima, & Shigeyuki Chaki. (2014). Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test. Psychopharmacology. 231(11). 2291–2298. 83 indexed citations

Iijima, Michihiko, Takao Yoshimizu, Kenichi Fukumoto, et al.. (2014). Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V_1B receptor antagonists: TASP0233278 and TASP0390325. British Journal of Pharmacology. 171(14). 3511–3525. 47 indexed citations

Koike, Hiroyuki, Michihiko Iijima, & Shigeyuki Chaki. (2013). Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats. Pharmacology Biochemistry and Behavior. 107. 20–23. 57 indexed citations

10.

Iijima, Michihiko, Hiroyuki Koike, & Shigeyuki Chaki. (2013). Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine. Behavioural Brain Research. 246. 24–28. 27 indexed citations

11.

Koike, Hiroyuki, Kenichi Fukumoto, Michihiko Iijima, & Shigeyuki Chaki. (2012). Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression. Behavioural Brain Research. 238. 48–52. 79 indexed citations

12.

Koike, Hiroyuki, Michihiko Iijima, & Shigeyuki Chaki. (2011). Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists. Neuroscience Research. 71. e199–e199. 34 indexed citations

13.

Iijima, Michihiko, et al.. (2010). Pharmacological characterization of repeated corticosterone injection-induced depression model in rats. Brain Research. 1359. 75–80. 78 indexed citations

14.

Iijima, Michihiko & Shigeyuki Chaki. (2006). An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy model. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(3). 622–627. 29 indexed citations

15.

Iijima, Michihiko, et al.. (2006). Effects of metabotropic glutamate 2/3 receptor antagonists in the stress-induced hyperthermia test in singly housed mice. Psychopharmacology. 190(2). 233–239. 34 indexed citations

16.

Shimazaki, Toshiharu, Michihiko Iijima, & Shigeyuki Chaki. (2006). The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats. European Journal of Pharmacology. 543(1-3). 63–67. 66 indexed citations

17.

Horikawa, Kazumasa, Yuki Minami, Michihiko Iijima, Masashi Akiyama, & Shigenobu Shibata. (2005). Rapid damping of food-entrained circadian rhythm of clock gene expression in clock-defective peripheral tissues under fasting conditions. Neuroscience. 134(1). 335–343. 32 indexed citations

18.

Chaki, Shigeyuki, Takeo Funakoshi, Toshiharu Shimazaki, et al.. (2005). Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists. Journal of Pharmacology and Experimental Therapeutics. 313(2). 831–839. 108 indexed citations

19.

Shimazaki, Toshiharu, Michihiko Iijima, & Shigeyuki Chaki. (2004). Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test. European Journal of Pharmacology. 501(1-3). 121–125. 64 indexed citations

20.

Iijima, Michihiko, et al.. (2002). Methamphetamine‐induced, suprachiasmatic nucleus‐independent circadian rhythms of activity and mPer gene expression in the striatum of the mouse. European Journal of Neuroscience. 16(5). 921–929. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact